EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression.
Mol Cancer. 2019 Nov 20;18(1):165. doi: 10.1186/s12943-019-1073-4.
Mol Cancer. 2019.
PMID: 31747941
Free PMC article.